Ole Vahlgren
Amministratore Delegato presso Aj Vaccines A/S
Patrimonio netto: 552 428 $ in data 31/05/2024
Profilo
Ole Vahlgren is currently the Chief Executive Officer at Aj Vaccines A, the Director at Go-Pen ApS, and the Director at Blue Cell Therapeutics ApS.
Previously, he held the position of President & Chief Executive Officer at Otsuka Pharmaceutical Europe Ltd.
and was a Director at Camurus AB from 2020 to 2024.
Mr. Vahlgren has an MBA from Copenhagen Business School and a graduate degree from the Technical University of Denmark.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CAMURUS AB
0.02% | 31/12/2023 | 10 000 ( 0.02% ) | 552 428 $ | 31/05/2024 |
Posizioni attive di Ole Vahlgren
| Società | Posizione | Inizio |
|---|---|---|
Go-PEN Aps
 Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Direttore/Membro del Consiglio | - |
Aj Vaccines A/S
 Aj Vaccines A/S BiotechnologyHealth Technology Part of AJ Biologics Sdn. The company is based in Copenhagen, Denmark. Bhd., AJ Vaccines A/S is a Danish pharmaceutical company that develops and manufactures vaccines against serious infectious diseases, as well as diagnostic and therapeutic solutions. The CEO of the company is Ole Vahlgren. | Amministratore Delegato | - |
| Blue Cell Therapeutics ApS | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ole Vahlgren
| Società | Posizione | Fine |
|---|---|---|
| CAMURUS AB | Direttore/Membro del Consiglio | 08/05/2024 |
Otsuka Pharmaceutical Europe Ltd.
 Otsuka Pharmaceutical Europe Ltd. Medical DistributorsDistribution Services Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK | Amministratore Delegato | - |
Formazione di Ole Vahlgren
| Copenhagen Business School | Masters Business Admin |
| Technical University of Denmark | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CAMURUS AB | Health Technology |
| Aziende private | 4 |
|---|---|
Otsuka Pharmaceutical Europe Ltd.
Otsuka Pharmaceutical Europe Ltd. Medical DistributorsDistribution Services Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK | Distribution Services |
Go-PEN Aps
Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Health Technology |
Aj Vaccines A/S
Aj Vaccines A/S BiotechnologyHealth Technology Part of AJ Biologics Sdn. The company is based in Copenhagen, Denmark. Bhd., AJ Vaccines A/S is a Danish pharmaceutical company that develops and manufactures vaccines against serious infectious diseases, as well as diagnostic and therapeutic solutions. The CEO of the company is Ole Vahlgren. | Health Technology |
| Blue Cell Therapeutics ApS |
- Borsa valori
- Insiders
- Ole Vahlgren
